chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Suspected vaccination failure; Shingles; Pinched nerve; Rash; Slight sorenss/dealing with severe pain caused by shingles; sore arm; Little painful; Neck pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles), pain in arm (Verbatim: sore arm), pain (Verbatim: Little painful), neck pain (Verbatim: Neck pain), pinched nerve (Verbatim: Pinched nerve), rash (Verbatim: Rash) and pain (Verbatim: Slight sorenss/dealing with severe pain caused by shingles). Rechallenge with Shingrix was positive. The outcome of the vaccination failure was unknown and the outcome of the shingles, pinched nerve, rash and pain were recovered/resolved and the outcome of the pain in arm and pain were recovered/resolved (duration 2 days) and the outcome of the neck pain was recovered/resolved (duration 4 days).   The reporter considered the vaccination failure, shingles, neck pain, pinched nerve, rash and pain to be possibly related to Shingrix and Shingrix. The reporter considered the pain in arm and pain to be possibly related to Shingrix.   The company considered the vaccination failure, shingles, neck pain, pinched nerve, rash and pain to be possibly related to Shingrix and Shingrix. The company considered the pain in arm and pain to be possibly related to Shingrix.   Additional Information: GSK Receipt Date: 16-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that based on the horror of this disease and the fear of getting shingles, she got both Shingrix shots. The first Shingrix shot made her arm sore and a little painful for two day and with the second shot of Shingrix very slight soreness for one day.  The reporter stated that it all started with four days of neck pain. The doctor initially thought she had a pinched nerve but then her pain worsened and a rash developed and it was shingles. The reporter further stated that she was dealing with severe pain caused by shingles was tough. The patient was knowing more about shingles would had been incredibly helpful. The reporter stated that nothing to be concerned about basically. The reporter further stated that definitely, she would recommend theses Shingrix shots and nothing to be scared or concerned about.  The reporter further stated that people over 50 be protective and talked to a doctor or pharmacist about shingles prevention. The reporter thought that the event might had been related to the drug. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Patient received first dose Moderna at pharmacy on 3/2/2023. Received 2nd dose Moderna today at the Health Department. Vaccine invalid since it is two weeks too early.
SYNCOPE SEVERAL TIMES WITHIN 20 MINUTES...PT WAS DEHYDRATED... LOW BP AND PULSE RATE.
Patient on 02/09/21 starting having slow thought process and weakness in left arm and hand and had little strength in left hand and was dropping things. patient was scheduled for ct scan for headaches later that week. Called and got ct scan to be done state. Patient had a CT scan on 02/09/21 which was negative and saw the doctor on 02/12/21 and he ordered an MRI which showed patient had a CVA, cerebrovascular accident-stroke, MRI results revealed the CVA.
Patient experienced a fever, chills, and body aches after taking the Shingles vaccine.
ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN IATROGENIC HYPOTENSION ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
This spontaneous report was received from a medical assistant and refers to a 12-month-old patient of unknown gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 27-SEP-2016, the patient received an improperly stored dose of VARIVAX (exact dose and route of administration were not reported, lot # M009768, expiration date: 23-FEB-2018). It was reported that the administered dose of VARIVAX was improperly stored at -3.5 degrees Celsius (C) for 1 hour and 6 minutes. There was no previous temperature excursion. Data logger was involved. No symptoms were reported. This is one of several reports received from the same reporter. Additional information is not expected as all relevant information has been received.; Sender's Comments:  US-009507513-1610USA011133:
Initial report was retrieved via a search of scientific literature on 14 May 2014. This case contains information for 1 of 5 patients whose clinical data were provided. Information regarding the other 4 patients are captured in case numbers 2014SA063502, 2014SA063511, 2014SA063513 and 2014SA063514. Verbatim from the abstract: Background: Fever, leukocytosis, and large local reactions following the pneumococcal polysaccharide vaccine (PS23) have been described only in isolated case reported in the adult literature. Such atypical reactions can pose difficulty to providers when determining management. Patients experiencing this noninfectious reaction may receive unnecessary treatment if the diagnosis of robust inflammatory response to the PS23 vaccine is not considered. Observations: This is a clinical case series of 5 adult patients who received the influenza and PS23 vaccines and experienced a cellulitis-like reaction, fever, and leukocytosis in the days following vaccination. Four of the five patients received the influenza and PS23 vaccines in the same arm. The patient who received the vaccines in opposite arms had the local findings in the arm that received the PS23 vaccine. All 5 patients sought care and 4 were admitted to the hospital for observation or treatment with intravenous antibiotics. Conclusions: This case series highlights potential side effects of the PS23 vaccine that are not well described in the adult literature. Antibiotics were not helpful in treating these patients' local and systemic symptoms. Patients with histories consistent with that highlighted in this case series may avoid antibiotics and hospitalization if the providers recognize these symptoms as a noninfectious reaction to the PS23 vaccine. Regarding this case which involves a 20-year-old male patient, with a medical history of smoking, who had received on an unspecified date the following vaccines: an injection of influenza vaccine (manufacturer, lot number, route and anatomical side of administration not reported) and an injection of 23 valent pneumococcal polysaccharide vaccine (manufacturer, lot number, route and anatomical side of administration not reported) vaccine in the same arm. Within 1 day after the vaccination, the patient developed fever with a maximum of 103 degrees F, vomiting and rigors. The patient also developed local erythema, edema and warmth at the site of injection. The patient had significant leukocytosis with a white blood cell (WBC) of 22.8 K/uL. The patient was hospitalized (dates not reported). He received a corrective treatment with antibiotics in the hospital and post discharge. According to the reporter, within 5-7 days all patients experienced improvement in the skin findings and resolution of the systemic symptoms. Outcome was recovered for systemic symptoms and unknown for local reaction. Documents held by sender: none.
Fever and body aches started day after vaccine given. She went to ER, temp. of 102.1 degrees F. Tx: TYLENOL, MOTRIN, IV fluids. Sx fully resolved within 24 hr.
patient received full course of pfizer vaccine, and approximatly 7.5 weeks later developed COVID-19 requiring hospital care.
Shortness of breath...numerous tests of lungs and hearts normal except barochial tube lympt nodes were noted swollen
2 weeks prior to vaccination (12 Jan) patient was seen for 4yr L breast mass. Referred for breast ultrasound. Patient underwent COVID vaccination 04Feb. Noted approx 16Feb to have increasing swelling in axillary region. Pt underwent breast ultrasound on 23Feb found to have breast mass and atypical appearing axillary lymph nodes, recommended for biopsy. Followed up with provider 25Feb and was referred to General Surgery. 08Mar had initial surgery consult, symptoms had modest improvement, recommended by surgery to monitor symptoms and defer 2nd COVID vaccination. 13MAR - axillary lymph node swelling returned 15Mar - patient was recommended by immunizations provider and nurse to defer 2nd vaccination and return to surgery for likely excisional biopsy of axillary lymph node and breast mass. Awaiting final surgery input on treatment plan.
Rash like lesion (papules) on both hands.  Possible smallpox vaccinia, 6-7 papules on both hands.
Patient received ZOSTAVAX from pharmacy on 10/21/15. She noticed a rash on 10/23/15. She visited her doctor on 10/23/15 and her doctor told her that although it is rare that he believes patient developed shingles after receiving the vaccine. Pt is still currently breaking out with rash although they are breaking out further apart.
Headache, sinus pressure, runny nose, cough, slight chest discomfort associated with cough, questionable chills (unknown if fever), low back pain, increased urination
This spontaneous report was received from a registered nurse refers to an approximately 74-year-old male patient (the physician) with no pertinent drug reactions/allergies. Current condition included prone to asthma. On 03-JAN-2013 patient was vaccinated with dose 2, 0.5 millilitre (ml) PNEUMOVAX23 (lot#1850AA, expiration date 28-JUL2013) intramuscularly (IM). The patient was vaccinated with dose 1 PNEUMOVAX23 (lot#, expiration date and route not reported) approximately on an unknown date in 2002 (reported as more than 10 years ago). No concomitant medications were reported. On 03-JAN-2013 patient's left arm became red, swollen and hard at the injection site and appeared to be cellulitis. He had limited mobility of his left arm due to the swelling. No laboratory diagnostic tests were performed. Treatment was not rendered for the events. Patient sought medical attention for the events. The reported events did not resolve at the time of this report. This is one of the reports received from the same reporter. Additional information has been requested.
Throw up the day after twice, body aches, swollen lymph nodes on right armpit that throbbed and sent shocks through my chest shoulder and arm, severe fatigue where I slept multiple days for 16-20 hours, severe migraines, losing balance/stumbling, tripping & falling, dizziness, severe nausea, cold chills and sweats every night, also had a large wart pop up on my right had  that throbbed and made my hand feel broken   Most ot these symptoms lasted 7-9 days  Currently I still get cold sweats and chills every night and am still very nauseous. My balance is still off.
Patient received Pfizer as 1st dose on 03/19/21 and was inadvertently given Moderna for 2nd dose on 4/21/21.
Warm at injection site. Swollen arm at injection site. Saw MD 6-23-18 diagnosed cellulitis. Per call 6-26-18 it is improving w/Antibiotic Tx.
He developed an unprovoked  DVT in his right leg that led to a pulmonary embolism that led to  severe pulmonary hyperttension that led to dyspnea on exertion.
On 10/08 patient developed pain on right side of neck.  This was followed by swollen lymph nodes in the same area that appeared red.  10/14 left side of neck had swollen red appearing lymph nodes with no pain.  Denies sore throat, ear pain, fever.  She also had malaise but thought it may be due to her menstrual cycles since that is usual.  She also reported on 10/8 bone pain in left shoulder same time as the beginning of the swollen lymph nodes.  She has not seen her physician yet, but will call for an appointment today.
postherpetic neuralgia; shingles; Information has been received from a lawyer referring to a female patient of unknown age. Information about concurrent condition, history condition and concomitant medication was not reported. On or around 15-JUL-2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered from an acute onset of painful vesicular rash on the right side and was diagnosed with shingles and postherpetic neuralgia. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the vaccine. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events shingles and postherpetic neuralgia were considered to be not recovered and causal relationship was assessed as related.    The lawyer considered the events shingles and postherpetic neuralgia to be disability.
BREAKTHROUGH COVID INFECTION, TESTED POSITIVE ON 08/28/2021. PATIENT FULLY VACCINATED ON 03/11/2021.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On an unspecified date the patient was vaccinated with ZOSTAVAX, 1 DF, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 08-MAR-2016 the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster or shingles. The patient has been prescribed VALTREX for management of his symptoms and pain. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
PT REPORTED THAT APPROXIMATELY 6 HOURS AFTER GETTING THE SHOT HE LOST CONCIOUSNESS AND EMERGENCY SERCIVES HAD TO BE CALLED. HE WAS FOUND TOP HAVE LOW PRESSURE. PT IS DOING OK NOW
episodes of dizziness; offbalance; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (episodes of dizziness) and BALANCE DISORDER (offbalance) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (episodes of dizziness) and BALANCE DISORDER (offbalance). At the time of the report, DIZZINESS (episodes of dizziness) and BALANCE DISORDER (offbalance) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Patient received vaccinations on 04/24/2017 and within 24 hours patient developed a red lump on her left thigh. This lump lasted for 2 weeks and only subsided with a course of cephalexin.
Had episode of syncope immediately following vaccination with HPV. Six weeks later had 2 more episodes syncope with nl MRI nl EEG.
Received the vaccine at 1038a. 1045 developed minor tongue tingling. Called the RN she gave me 25mg Benadryl. By this time whole tongue became tingly and the roof of my mouth started to feel numb. A minute later throat started to feel full and it became hard to swallow. This feeling of it being hard to swallow, came with a painful headache and some chest pain.  Once in ER, was given more Benadryl, Epi, Lorazepam,  and Protnox.  The feeling in my throat and the difficulty swallowing slightly improved 25min after the oral Benadryl.  It took about a little over an hour from the  onset of symptoms to start to feel they were resolving.
I previously had a severe reaction to my second Pfzier vaccination.This included nausea, severe vomiting, headaches, muscle aches, and loss of energy. Before receiving my Pfzier booster shot I explained very strongly I believed I have a problem with getting this vaccine. With a smile she told me it was a very odd event and the chances of it happening again were slim. Though I disagreed, being a hospital employee for years I trusted she wasn't deceiving me. Not two hours after receiving the shot I became warm and fuzzy. Not a high feeling but a confused scary feeling that scared me because I couldn't breathe. I tried to calm myself down when the vomiting started. I threw up from Tuesday evening until early Thursday morning though after alot if the time it was dry heaves because nothing was left in my system. This all started the 21 of December and it is now the ,24th. I still haven't eaten solid food but thank God I'm not dry heaving anymore. I'm still nauseated, can't get warm yet shirt is filled with sweat, and can exzert myself without being out of breath. I am not sure what is going on here as far as reporting these incidents. Most people don't know how or are to sick to find a site to report issues like this. Are serious side effects of the vaccines being downplayed and reporting them made difficult for people especially the older generation who are unfamiliar with how to find a reporting site on the internet. I believe so.
This case was reported by a consumer via interactive digital media and described the occurrence of pain in a female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX, at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain. On an unknown date, the outcome of the pain was not reported. It was unknown if the reporter considered the pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The consumer reported that her aunt received SHINGRIX and the pain was awful. No consent for follow up and no additional information available.
Client received H1N1 inactive influenza vaccine and within 3 minutes developed a headache that last about an hour. 20-30 minutes later she started having tightness, burning in her chest, sore throat, post nasal drainage and coughting. She took some Benadryl and went to bed. During the night she had a productive cough of yellow colored mucus. She denies fever, rash, swelling or tingling of lips. On Oct. 23, 2009 she went to her HCP and was told that she was having an allergic reaction. She was prescribed Augmentin, Singulair, Flovent, Albuterol and Ventolin.
Instant dizziness that lasted 12 days with first shot and constantly since second shot on 5/22.  Intolerance to any foods with histamines in them now (dizzy reaction) and presumed bacterial overgrowth. The overgrowth happened initially with a progestin-only injection in 2015.
Loss of taste, smell, headache. I received 3 Pfizer vaccines including last booster. After my booster I felt really sick for a week. Fever, chills, swollen lymph nodes, fatigue, and loss of taste and smell. Since then I've had bad headaches, swelling and sticky mucous in my nose, and a total loss of smell and taste. I'd love to understand whether you've seen other cases like this and when side effects will resolve.
mom presented child @ 1045AM stated pt started vomiting while walking to school this AM temp 98.6;pt appears tired;had dry cereal & coffee for breakfast;
Approx. 24 hours, post vax, the infant experienced a temperature of 38.5C and began seizing. This lasted approx. 15 minutes. About 7 hours later, he seized again with no associated fever, lasting 10 minutes. He seized again approx. 20 hours after the 1st seizure. Discharge DX: Febrile seizure.
Fever, shivering, temperature of 104,  after taking 1000mg Tylenol, still had shaking/chills, headache, nausea temperature of 103.  Took again 1000mg Tylenol.  No information provided after Tylenol was taken.
A report has been received from a physician via a medical assistant, concerning a 6 year old female patient. No relevant history, concomitant disease or concomitant medications of the patient were reported. Patient was a healthy child, no medical issues. The patient had received nasal FLUMIST quadrivalent, on 28-Sep-2013. It was reported that the patient contracted the flu on 19-Nov-2013 after being vaccinated with FLUMIST this season. Patient was treated with TAMIFLU. The outcome of the event of flu diagnosis after vaccination with FLUMIST was unknown. The reporter assessed the event to be non-serious.
Patient stated that during past vaccines she had gotten very dizzy but never fainted. Her mother later stated she had fainted in the past. Patient was very anxious to receive the vaccine but had a support person(her aunt) with her that helped her during the immunization. She did great while receiving the vaccine, then about 2-3 minutes after she expressed the was very hot and was getting dizzy. The patient said she was going to faint. The support person and the RPh supported her so she did not fall out of the chair and she fainted for about 20-30 seconds. She gained consciousness and we gave her some water and fanned her with air. The patient continued to recover and started feeling well again quickly. We had the patient wait 30 minutes post vaccine with no other adverse events.
1.  Within 3-4 weeks of second dose, I began to experience extremely blurred vision.  Cloudy to the point that it impedes my ability to drive.  I had a comprehensive eye exam done and my vision is near perfect.  The optometrist was unable to find anything wrong with my eyes.   2. Within 3-4 weeks of second dose, I began to feel extreme fatigue.  Sleeping 9-10 hours a night and needing a 1-2 hour nap early afternoon.  I went to my primary care and had a full blood panel run and my bloodwork was normal. 3. Within 3-4 weeks of second dose, I started rapidly gaining weight.  To date, I have gained approximately 25 pounds since June 2021 4. Extreme lower back pain 5. Chronic headache and nausea.  Every single day,
About a week after receiving Moderna Bivalent booster I  have been consistently experiencing breathing difficulty, dizziness, confusion and light headiness, extreme exhaustion after mental or physical exertion, chest pain, ringing in the ears, weakness in legs and arms. Lower left leg and left foot circulation issues.  Sleep on side or on a few pillows because of breathing issues. Insomnia.  Completely debilitating that I cannot live a normal life. Will seek ER treatment if symptoms continue.